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ABSTRACT
Background
Overweight and obesity have significant impact and consequences on women leading
to reduced quality of life, comorbid conditions and premature mortality. Many
healthcare providers lack adequate training and the time to properly treat overweight
and obesity. Algorithms have been shown to improve clinical knowledge and save
time.
Objectives
To develop an algorithm for weight loss assessment and treatment to aid in the
clinical decision-making process while improving the quality of care for overweight
and obese clients in an efficient manner that can be replicated.
Methods
After an extensive literature review to identify best-practice guidelines for weight loss
a retrospective chart review was performed at two women’s health clinics located in
St. Louis County over a five-month period. For three consecutive appointments 50
patient charts were audited and compared to current evidence-based practice
guidelines. Any gaps between the office practice and the guidelines were identified. A
weight loss algorithm was then developed incorporating clinical assessment methods,
lab work, anthropometric measurements and appropriate referrals.
Results
Fifty patient’s charts spanning from 10/2014-01/2017 were examined and compared
to evidence-based clinical guidelines for weight loss. The comparison revealed gaps
between evidence based research and practice related to lack of time, not wanting to
add additional work for the staff/ healthcare providers, and forgetting to include
various assessments and referrals. To improve the assessment practice while saving
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valuable clinical time, an algorithm was recommended as a template to use in the
electronic health records (EHR) along with a hard-copy paper form. Additional
measurements were added to the women’s health clinic computer system for neck and
waist circumference by their IT staff, and a packet was developed containing
assessment questionnaires for patients to either complete prior to coming to the initial
appointment or fill out while in the waiting room. This weight loss algorithm was
then presented to the participating clinician for implementation for a future pilot
study.
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Introduction
The objective of this clinical scholarship project is to examine evidence-based
algorithms for weight loss and obesity, compare them to current practice in a
women’s health clinic based near St. Louis, Missouri and to develop a functional/
duplicable algorithm which would guide clinical decision-making to treat overweight
and obesity in women. This algorithm will help standardize treatments for clinicians
and encourage women to be the most successful at losing weight, thus decreasing the
incidence of mortality and morbidity related to obesity. Properly and consistently
treating overweight and obesity will help reduce cardiovascular disease, type 2
diabetes, certain cancers, osteoarthritis, infertility, as well as other medical conditions
in this population (National Heart, Lung, and Blood Institute, 2012).
Background
Obesity is now one of the most visible, but neglected public health problems
globally. According to the World Health Organization (WHO, 2014), the prevalence
of obesity globally has more than doubled between 1980 and 2014. Around the world,
there are now over 1.9 billion overweight adults and of these 600 million are obese
(WHO, 2014). The United States, a country that accounts for only 5% of the world’s
population, comprises 13% of those who are overweight and obese (Murray, Ng, &
Mokdad, 2013). Approximately two thirds of American women are overweight or
obese, while 9.9% are extremely obese (Centers for Disease Control and Prevention
[CDC], 2015; Flegal, Kruszon-Moran, Carroll, Fryar, & Ogden, 2016). In the state of
Missouri, just over 59% of women are overweight (CDC, 2014), while women
residing in the city of St. Louis fall closely behind this statistic at 58.8% (Department
of Health, City of St. Louis, 2015).
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The increasing prevalence of obesity predicts rising financial burden from
associated comorbidities, especially cardiovascular disease, diabetes and cancer
(Wang, McPherson, Marsh, Gortmaker, & Brown, 2011). These trends are expected
to continue in the United States, estimating 65 million more obese adults by 2030.
Medical costs to treat obesity and its related diseases are expected to increase $48-66
billion per year for this same period (Wang et al., 2011). Another study by Schmier,
Jones and Halpern (2006), analyzed insurance claims data and discovered overweight
and obese employees had consistently higher work-related costs, such as; sick leave,
disability and workplace injuries.
Obesity leads to serious health consequences, including increased risk of
premature death to comorbid conditions that reduce the general quality of life.
Overweight and obesity directly and indirectly affects women. Cardiovascular disease
is the number one obesity-related cause of mortality of women and one in four
women will die from heart disease (Xu, Murphy, Kochanek, & Bastian, 2016). While
coronary heart disease (CHD) is the number one killer for both men and women in
the United States, coronary microvascular disease and broken heart syndrome (stressinduced cardiomyopathy) target more women (National Heart, Lung and Blood
Institute, 2014). Nearly 64% (two-thirds) of women who die suddenly from CHD
have no prior symptoms (American Heart Association, 2012).
Certain cancers such as ovarian, cervical and breast all have a higher
incidence in overweight or obese women (Kulie et al., 2011). The duration of how
long a woman has been overweight has been shown to impact the risk of developing
these cancers, including endometrial (Arnold et al., 2016). Renehan, Tyson, Egger,
Heller and Zwahlen (2008) go on to include an association between a higher body
mass index (BMI) and gallbladder, esophageal adenomas and renal cancers in
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overweight or obese women. A weaker link was noted in women for pancreatic,
postmenopausal breast, thyroid and colon cancers, while leukemia, multiple myeloma
and non-Hodgkin’s lymphoma affect both men and women (Renehan, Tyson, Egger,
Heller, & Zwahlen, 2008).
An overweight or obese woman is also more likely to develop metabolic
syndrome, type 2 diabetes or have problems with infertility related to polycystic
ovarian syndrome (PCOS) (Hu, 2003). Obesity contributes to various reproductive
disorders such as anovulation, menstrual issues, infertility, miscarriage, difficulties
with assisted reproduction and adverse pregnancy outcomes (Dag & Dilbaz, 2015;
Jungheim, Travieso, & Hopeman, 2013). There is also an association with decreased
intention, initiation and duration of breastfeeding in mothers who are obese (Kulie et
al., 2011).
Overweight and obesity in pregnancy not only increases health risks for the
woman, but also for her child. This is due to a higher incidence of preterm birth
associated with this condition (Cnattingius et al., 2013; McDonald, Han, Mulla, &
Beyene, 2010). Research also links obesity to an increase in preterm birth, to
childhood and adult obesity, cardiovascular disease, and type 2 diabetes (Leddy,
Power, & Schulkin, 2008). Nearly one in four (23.4%) women are obese prior to
becoming pregnant (Osterman et al., 2013). A pregnant woman's preconception
weight can influence the child’s health (Beil, 2016; Patel, Pasupathy, & Poston,
2015). If she has a higher body mass index (BMI) prior to becoming pregnant it may
be a determinant in her child’s risk for cardiometabolic disorders later in adulthood,
thus perpetuating the obesity cycle for future generations (Beil, 2016; Patel et al.,
2015).
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The psychological effects of being overweight or obese are especially difficult
for most women. There are social and cultural implications involved as well (Carlson
& Seacat, 2014). The stigma towards obese women can lead to low self-esteem and
depression (Kulie et al., 2011). A woman experiencing weight-stigma is increasingly
vulnerable to not only depression and esteem issues but to a poor body image,
exercise avoidance and maladaptive eating behaviors (National Obesity Observatory
[NOO], 2011). The NOO (2011) goes on to state there is a bi-directional relationship
between obesity and mental health issues, with various levels of obesity, gender, age
and socioeconomic status being contributing risk factors.
Obstacles
Many obstacles can be attributed to why obesity counseling and treatments are
not adequately being done. Lewis and Gudzune (2014) stated the lack of provider
training, time, reimbursement and provider weight-bias as obstacles. According to
Forman-Hoffman, Little, and Wahls (2006) many primary care health care providers
(HCP) do not have adequate training in obesity treatments and are often unaware of
facility options for weight loss. Many clinicians believe the patient’s weight is related
to a lack of will power and is their own fault. Proper seating, exam tables, large blood
pressure cuffs, gowns, etcetera are not always available to accommodate these
patients (National Institute of Diabetes and Digestive and Kidney Diseases, 2011).
The patient-related barriers for weight loss and obesity treatments include feeling
embarrassed and facing disrespectful comments about their weight by the HCP or
staff. In a qualitative study by Metzgar, Preston, Miller, and Nickols-Richardson
(2015) further patient barriers included: life transitions, internal and environmental
pressures, health status changes, lack of accountability and social support.
Review of the Literature

WEIGHT LOSS ALGORITHM

8

The review of literature included databases from: Medline (EBSCO), 1946Present, Medline (OVID), 1946-Present, Google Scholar and Science Direct. Key
words: Adiposity, Barriers, Obesity algorithms, Overweight and obesity practices,
Primary care treatment for obesity, Weight loss, Weight loss methods, Weight loss
guidelines, Guidelines for weight loss, Guidelines for overweight and obesity. The
populations consisted of; Weight loss in women, Obesity treatments for Hispanic,
African Americans, Asian and Indian women. Years included in the literature search
were from 2000 to present. Limiters included: Abstracts available, full text online,
peer-reviewed, English language, humans, female, and adults 19 and older. The
searches produced 820,000 articles. Of the articles, 210 were relevant and 57 were
used in the development of this project. Article selection was determined by whether
each article was evidence-based, peer-reviewed and could be applied to women.
Guidelines for the algorithm were evaluated and selected according to the Agency for
Healthcare Research and Quality’s guideline summaries.
A literature search revealed that the American Society of Bariatric Physicians,
now called the Obesity Medicine Association, has an algorithm developed from
evidence-based research (Obesity Medicine Association, 2017). This obesity
algorithm is very comprehensive and details many options for treatment. A condensed
version of this algorithm was developed by Horn (2013). The American Association
of Clinical Endocrinologists (AACE) and the American College of Endocrinology
(ACE) (Garvey et al., 2014) have an algorithm which includes more detailed staging
of obesity and breaks down treatment and risk factors according to these stages. The
American Diabetes Association also has an algorithm recommending therapies for
weight loss, lifestyle choices and use of medications to treat type 2 diabetes in
overweight and obese patients (American Diabetes Association, 2016).
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The general consensus of high-quality evidence in developing an algorithm
includes the following elements falling under the Five “A”s; Ask, Assess, Advise,
Assist and Arrange (Fitch et al., 2013; National Health and Medical Research
Council, 2013). Many of the evidence-based studies concurred in regard to the five
“A”s, however, they did not include the diagnosis and treatment of overweight and
obesity specifically for women.
Baseline anthropometric measurements are considered BMI, waistcircumference, weight and height. The 2013 AHA/ AAA/TOS Treatment AlgorithmChronic Disease Management Model for Primary Care of Patients with Overweight
and Obesity further classifies obesity according to BMI; 30-34.9 (Class I), 35-39.9
(Class II) and >40 (Class III) in (Jensen et al., 2013). The AACE and the ACE states
in the 2014 “Advanced Framework for a New Diagnosis of Obesity as Chronic
Disease” some specifics to clinical diagnostics and staging of obesity (Stages 0-2).
The evidence strongly suggests the use of laboratory and other diagnostic tests such
as blood pressure, fasting glucose, fasting lipid panel, creatinine along will hepatic
transaminases and a full review of systems (Garvey et al., 2014). Other
recommendations include fasting insulin, endocrine function along with a thorough
history, family history, evaluation of risk factors and comorbid conditions.
Once the determination to lose weight has been made by the patient, the HCP
should explain the risk factors involved and that a 5-10% weight reduction could
significantly impact health (Fitch et al., 2013). The socio/social component, needs to
be evaluated which includes the patient’s readiness to lose weight. Other factors to
consider are realistic weight goal-setting, age and stage of life, cultural needs,
ethnicity, economic and social circumstances, cognitive or physical disabilities and
support system (National Institute for Health and Care Excellence [NICE], 2014)

WEIGHT LOSS ALGORITHM

10

Physical activity was universally agreed upon in every study as an important
element for weight loss. The evidence suggests some form of aerobic exercise > 150
minutes per week. Approximately 200 to 300 minutes per week of higher levels of
physical activity are recommended to maintain weight or minimize regaining weight
(Jensen et al., 2013).
Diet suggestions included estimating total energy needs according to the patient’s
lifestyle (sedentary, low active, active, and very active) and adjusting caloric and
nutritional intake accordingly. The Academy of Nutrition and Dietetics in the 2014
Adult Weight Management Guideline details patient preferences, beliefs, attitudes
and motivations as important components as well. The North American Association
for the Study of Obesity (NAASO) and National Heart, Lung, and Blood Institute
(NHLBI) have educational tools for reading labels, counting calories, meal planning,
portion size and food substitution suggestions in the Practical Guide for
Identification, Evaluation and Treatment of Overweight and Obesity in Adults (2000).
This guideline contains an algorithm for treatment as well as follow up, which was
seldom mentioned in the other studies.
According to recommendations from the Endocrine Society Clinical Practice
Guideline pharmacological interventions are recommended for BMI > 27 with any
comorbidity or a BMI > 30 (Apovian et al., 2015). This guideline also recommended,
when possible, substituting current weight-causing medications for those that did not
encourage weight gain. Multiple studies, including Yumuk et al. (2015) suggested
when appropriate, treating with various drugs such as; Orlistat, Lorcaserin,
Phentermine/ topiramate, Bupropione/ naltrexone or Liraglutide.
Monitoring the patient’s weight is recommended to evaluate if treatments are
effective or need to be adjusted. Office visits approximately once a month for the first
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three months, then every three months during the first year to assess the patient’s
weight and measurements are recommend by Bays et al. (2013). While the Obesity
Action Coalition (2017) suggests follow-up appointments once a month until target
weight is achieved or a 5%-10% weight reduction. Most guidelines do not mention a
specific timeline for follow-up appointments unless the patient has undergone
bariatric surgery, but that they are encouraged. A calibrated scale at home, the use of
phoning or emailing in their home weight, the use of mobile applications to monitor
diet, weight and exercises are all proving to be effective as well to help patients stay
focused on their goals (Allen, Stephens, Dennison Himmelfarb, Stewart, & Hauck,
2013).
A collaborative treatment plan is imperative. Evaluation of the patient’s needs
will be a priority to a successful weight loss program. Some patients will need
treatment, in addition to their primary HCPs, from a registered dietician, psychiatrist,
psychologist, physical therapist, personal trainer or social worker (Tsai & Wadden,
2009). Patients with insufficient or no insurance coverage will have more challenges
and may need help locating the assistance they require. Possible community resources
to consider include exercise facilities, weight loss groups for support, transportation,
access to quality food sources, and childcare (National Institute of Diabetes and
Digestive and Kidney Diseases, 2017). Everyone involved needs to work
collaboratively and synergistically to help the patient achieve the desired goal.
When current guidelines were examined, what was found were many ways to
treat overweight and obesity, however gaps in the literature included the previously
mentioned lack of testing and follow-up timeframes. Also, ethnocentric and gender
specifity was insufficient, however if ethnicity was mentioned often the study was
conducted in a European country. There is a lack of high quality studies for weight
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maintenance and prevention for normo-weight/ BMI individuals, as well as a lack of
qualitative research on the patient’s experiences and preferences with prevention,
overweight and obesity interventions (Brauer et al., 2015). The “Clinical Practice
Guidelines for Healthy Eating for Prevention and Treatment of Metabolic and
Endocrine Diseases in Adults” outlined nutritional strategies for prevention and
treatment for disease and conditions associated with overweight and obesity
(Gonzalez-Campoy et al., 2013). Finally, according to Apovian et al., (2015) data
regarding BMI gender variations is inadequate.
A simplified algorithm applicable and duplicable for everyday practice,
inclusive for patients of all weight categories and stages is not available. The various
obesity algorithms found were either very time consuming to evaluate or over
generalized and not applicable in an easy to follow format. A practical application
would be an algorithm designed from evidence-based guidelines, entailing a
successive approach for each appointment. Clinical judgment should supersede the
algorithm as needed per patient requirement.
Purpose
This project is designed to help improve the care delivery system of how
clinicians treat overweight and obesity. This is done through quality improvement of
current practice in the women’s health setting by a weight loss algorithm with
recommendations from obesity experts, evidence-based research, and guidelines. The
algorithm allows a more standardized and duplicable approach for HCPs to treat this
disease, directed specifically for women’s biological and emotional needs throughout
this process, to ensure all aspects of obesity care are being addressed. The algorithm
aims to inform practice about obesity and weight loss treatments, thus increasing
clinician knowledge, treatment plans, and improved health outcomes for overweight
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and obese female patients in a more efficient manner.

Method
Implementation of this project began with a thorough literature search to
identify best-practice guidelines for weight loss and any gaps pertaining to obesity
treatment in women. Any existing weight loss algorithms were reviewed for clarity
and clinical practicality.
This clinical project took place at two women’s health clinics located near St.
Louis, MO. The patient population was 50 women, 19 years old and older. The
women have a BMI of > 25 and a waist circumference of > 35 inches (88cm).
Permission to audit patient information was granted by the office manager at the
healthcare facility. All necessary HIPPA documentation was processed. The project
was approved by the IRB of the University of Missouri- St. Louis (Appendix A).
A retrospective audit tool was developed to compare evidence-based
recommendations for weight loss to the treatments provided to the patients. The tool
included items from the following guidelines; American Heath Association/
American College of Cardiology/The Obesity Society (Jensen et al., 2013), Academy
of Nutrition and Dietetics (2014), Canadian Task Force on Preventative Health Care
(Brauer et al., 2015), National Health and Medical Research Counsel (2013), National
Institute for Heath and Care Excellence (2014), the Institute for Clinical System
Improvement (Fitch et al., 2013) and The Endocrine Society (Apovian et al., 2015).
The audit tool displayed how often the recommended lab work, anthropometric
measurements, medication, exercise and motivation were reviewed in the clinical
setting for the initial and two subsequent appointments. The participant electronic
health records (EHR) were reviewed, pertinent information was identified within the
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audit tool and any discrepancies noted. This data was collected for a period of five
months and the 50 patient charts were dated from 10/02/2014 through 01/06/2017.
Data was extracted from each of the 50 charts and was compared for the frequency of
patients whose care included the recommended items from the guidelines.
Results
Fifty patient charts were audited for the first three consecutive visits for 71
items over the course of five months. After examination of the data analysis tool
some discrepancies and inconsistencies were noted. Research indicates that the
following assessments and tests (see below) be performed to treat overweight and
obesity. Most research did not state when exactly each of these should be done but
that it is recommended for better diagnosis and assessment for overweight and
obesity, however, according to Bays et al. (2013) weight loss patients should be
followed-up at least quarterly.
The labs collected at the initial appointment and as necessary include; CBC,
CMP, Lipid, TSH Reflex, Vit D levels, HgA1C, and urine analysis (Seger et al.,
2015). According to Steelman & Westman (2010) other forms of diagnostic testing
such as ECG, cardiac stress testing, sleep studies, ultrasound of the liver and resting
metabolic rate may indicated based on the results of clinical assessments and lab
results.
An algorithm for a standardized approach was developed. The first three
appointments follow a practical protocol allowing clinicians to address obesity with
continuity of care. This standardization facilitates obesity treatment as other HCPs
join the practice and are interested in treating this condition. The algorithm can be
used as a template for current obesity practice providers and for new HCPs.
Some of the recommended items included in the algorithm are anthropometric
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measurements such as: Body Mass index (BMI) to help define body fat based on
height and weight. The definition of overweight according to BMI is 25-29.9, while
obese is considered having a BMI of 30 or greater (U.S. Department of Health and
Human Services, 2007). Other forms of measurement include; neck circumference,
waist circumference, waist-to-hip ratio, bioelectric impedance, skinfold thickness, airdisplacement plethysmography, DEXA, dilution method, CT and MRI scan as
suggested by Hu (2008).
After analyzing the results there were some differences between the guidelines
and actual patient care noted. Under Patient History; cardiovascular, pulmonary,
gastrointestinal, psycho-social/ cultural, endocrine and tobacco and illicit drug use
were reviewed 100% of the time within the first three visits (See Table 1).
Neurologic, medical/surgical conditions, medicine/ food allergies and current
medications were reviewed at 98% of the appointments. Immune and eating disorders
were examined at 10% of time while the patient’s integument at 6%. Family history
was reviewed specifically for obesity and applicable familial diseases respectively
94% and 100% of the time.
Nutritional history, including a review of the patient’s 24-hour diet and eating
habits were documented 100% of the time within the first three appoints. While
physical activity was stated at 80%.
Vital signs, height, weight and BMI were taken and reviewed at each of the
three appointments 100% of the time. While the measurement of waist circumference
was performed 4% of the time and neck circumference at 8% within the first three
appointments. The comprehensive physical exam included nose, throat, neck
examined 100% of the time. Examination of the lungs, heart, abdomen,
musculoskeletal, and integument were performed 98% of the time.
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Recommended lab and bloodwork were taken at different portions of the time.
Renal blood test was performed 98% of the time while liver enzymes and electrolytes
96%. A fasting liver panel was completed 88% of the time, vitamin D 86%, thyroid
stimulating hormone with reflex 84%. A complete blood count was ordered 80% of
the time, hemoglobin A1C 46%, uric acid 6% and urine analysis and urine examine
for microalbumin were not done at all. Other diagnostic testing was done as indicated;
fasting insulin 62%, C-reactive protein, testosterone and other androgens 12%,
cortisol 6%. While glucose tolerance, prolactin, follicle stimulating hormone and
luteinizing hormone 2% of the time. Finally, estradiol, pregnancy test and iron studies
were not documented as done.
The category relating physical activity was as follows; assessment of physical
readiness 96%, assess mobility 100%, assess fitness level 96% of the time.
Behavior therapy review included looking at the patient’s triggers for
overeating or eating the wrong types of foods 86% of the time. Assessment of the
patient’s knowledge deficit of what to do to lose weight was performed within the
first three appointments 94% of the time. A look at the patient’s stress and support
system was examined at 92% of the appointments.
A review of the patient’s medications contributing to weight gain or difficulty
losing weight were performed 25% of the time and the medications were adjusted or
discontinued 20% of the time. It was noted that 48% of the time patients were started
on metformin. As this study progressed, medications known to encourage weight loss
were added. These specific medications were prescribed 76% of the time. Once added
they were continued within the three visits 76% of the time. Sixty-two percent were
changed to another weight loss drug or had dosing alterations, while 38% were
discontinued all together.

WEIGHT LOSS ALGORITHM

17

Finally, the use of electronic devices to assist in the weight loss process was
listed as reviewed during 4% of the visits. The various devices measured caloric
intake, physical activity, sleep schedules and some suggested recipes for the diets the
patients were following.
When clinicians at the project site were asked why they did not address weight loss or
follow the recommended guidelines, lack of valuable clinical time was the main
reason, forgetting certain assessments and not wanting to impose on support staff for
extra anthropometric measurements were also identified as factors. Lastly, one of the
clinicians stated she felt uncomfortable bringing up such a sensitive topic to
overweight women especially since she was of a slender build.
Discussion
In summary measurements such as vital signs, the assessment of mobility and
the discussion of the patients 24-hour diet were performed at every visit. Other items
such as the neck and waist circumference were done under 10% of the time. These
results are also listed in Table 1 and display the wide range of inconsistencies within
the three appointments. The evidence-based recommended guidelines were not
consistently followed.
Each of the above measurements and assessments should be looked at and
documented according to evidence-based guidelines (Steelman & Westman, 2010). It
is important to follow the recommended guidelines because without adequate
anthropometric measurements, monitoring the patient’s progress throughout treatment
is difficult. For example, a neck circumference in women can help determine an
obstructive sleep apnea risk (OSA) if > 16 inches. Kushida (2010), goes on to state
that neck circumference is one of the most powerful predictors of OSA, which
impacts the cardiovascular, neurological, endocrine systems.
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According to Moore and Cunningham (2012) the patient’s history is related to
their stress level, dietary behaviors and risk for obesity which should be routinely
examined. The use of the 24-hour food recall survey to assess dietary intake and
investigating the patient’s physical activity was recommend by Beechy, Galpern,
Petrone, and Das (2012).
Bays et al. (2013) mention that a fasting lipid panel should be performed to
evaluate cardiovascular risk, metabolic syndrome/ insulin resistance. Steelman &
Westman (2010) also recommend each of the tests listed above as routine laboratory
tests for weight loss assessment and treatment.
Research by Meriwether, Lee, Lafleur, and Wiseman (2008) states that
readiness, mobility and fitness level pertaining to physical activity should be
addressed. This would allow some insight into the patient abilities, preferences and
inclination towards exercise.
Patient triggers, knowledge deficits, stress level and support systems are all
things to consider. These behaviors are an important part of the weight loss
assessment according to Jacob and Isaac (2012) and ought to be incorporated into
these appointments.
For the patient’s medications, studies recommend reviewing and finding
suitable alternatives if possible for medications known to increase body weight
(Apovian et al., 2015). Bray (2013) suggests that using specific medications to help
treat overweight and obesity can be beneficial because they enhance behaviorallyinduced weight loss. Kumar and Aronne (2015) mention that obesity is a chronic
disease and should be treated with medication, if needed, to assist patients lose
weight. These studies go on to list some of the current FDA approved weight loss
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medication currently available.
Finally, monitoring weight, food intake and physical activity using mobile
applications have proved to be effective according to Allen, Stephens, Dennison
Himmelfarb, Stewart and Hauck (2013). The results of all the items in the chart audit
can be found in Table 1.
Development of Weight Loss Algorithm
To assist in closing the practice gaps for weight loss treatment and addressing
the main reasons as to why evidence-based practice was not being more uniformly
followed an algorithm was designed, for visits one (Appendix B), two (Appendix C),
and three (Appendix D). A template for clinical assessment and treatment that could
be used in the EHR system for the initial and two subsequent appointments was
designed. Evidence-based criteria specifically for the obesity treatment was included
in the algorithm. The template contains parameters recommend by guidelines to
improve assessment and treatment of overweight and obesity. This tool has a
sequential flow looking at History, Physical and treatment plans but also includes
Nutrition, Physical Activity, Behavioral Therapy, Weight Loss Medications and
Patient Goals. The clinician has the option to use this template as an algorithm to help
make decisions regarding treatment plans. For a HCP familiar with obesity treatments
the template would serve as a reminder to include specific assessments and to a new
clinician it would serve as a decision-making algorithm of treatment choices.
Patient Health History Form
The next portion of this project consisted of developing a Patient Evaluation
Heath History Form (Appendix E). The patient could either download the form
through email, if they have an electronic patient account set up, obtain through
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standard mail or fill out when they arrive at the clinical setting. This would allow for
better assessment and save clinical time. The form is based on the clinician algorithm
while using simpler lay language and is designed to be able to transfer the
information efficiently into the clinician assessment EHR. The ease of transferring
this information will save the clinician time and avoid asking redundant or timeconsuming questions, thus increase efficacy.
Obesity Parameters
Finally, a work-order was put into the women’s clinic IT department to
include neck and waist circumference along with the standard BMI, height and
weight measurements. This would serve as a reminder to get the necessary
assessment measurements. The parameters of neck and waist circumferences were
incorporated into the EHR Vital Signs and Measurements section. This involved
putting in an input-request through the office manager and it went through the proper
channels to the IT department. The extra measurements are considered a soft
parameter, meaning they are optional without an alarm. According to the evidence
previously cited, these measurements should be included for obesity treatment.
Limitations
The limitations for this project consisted of finding three consecutive weight
loss appointments. The appointments had to be for weight loss and not OB/GYN and
there was some degree of no-show appointments as well. This resulted in the audit
time spanning from 10/02/2014 through 01/06/2017; over that timeframe some of the
practice assessments and charting had changed. The results showed the discrepancies
of what assessments were not charted. In the process of completing the audit, data
was sometimes found in sections of the EHR that were not consistent with where it
should have been found so some data may have been missed. After observing many
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weight loss appointments in this clinical setting, the clinician often reviewed more
items and may have simply not documented all of them, thus the audit data does not
reflect this.
Implications and Future Direction
Implications for practice include utilizing this weight loss algorithm, patient
health history forms and new measurement parameters to improve overweight and
obese patient assessment and treatment. The trained obesity clinician and the new
HCP interested in treating this disease will have an assessment and diagnostic tool to
use accordingly. Finally, this algorithm will help close the gap between evidencebased research and clinical practice for treating overweight and obesity.
The future direction consists of training support staff and other clinicians of
new measurement parameters and assessment tools. Future projects could then
evaluate the effectiveness of the use of evidence-based algorithm in management of
overweight and obesity. A pilot study will then be done to evaluate improvement of
the recommended guidelines being addressed and documented.
Conclusion
Weight loss needs to be a multifaceted approach. Clinicians adhering to a
best-practice algorithm developed from the evidence will allow congruency and
continuity of care. There are numerous patient variables associated with losing
weight. Removing HCP and assessment tool inconsistencies from practice will give
overweight and obese women a greater opportunity to succeed at their weight loss
goals.
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TABLE 1
History:
Patient History: cardiovascular, pulmonary, gastrointestinal, psychosocial/ cultural, endocrine and tobacco and illicit drug use.
Neurologic, medical/surgical conditions, medicine/ food allergies and
current medications.
Immune and eating disorders.
Integument
Family History: obesity
Applicable familial disease
Patient Nutritional History: patient’s 24-hour diet and eating habits
Patient Physical Activity: Physical activity
Vitals/ Measurements
Vital signs, height, weight and BMI
Waist circumference
Neck circumference
Physical exam: nose, throat, neck.
Lungs, heart, abdomen, musculoskeletal, and integument
Lab work & Diagnostic Testing: Renal blood test
Liver enzymes, electrolytes
Fasting liver panel
Vitamin D
TSH w/ Reflex
CBC
HgbA1c
Uric acid
Urine Analysis
Additional Testing as Indicated:
Fasting Insulin
C-reactive protein & Testosterone and other androgens
Cortisol
Glucose tolerance, prolactin, follicle stimulating hormone and
luteinizing hormone
Activity
Physical activity: readiness
Mobility
Fitness level
Behavior:
Triggers or eating wrong kinds of food
Knowledge deficit
Stress and Support System
Medications:
Contributing to weight gain/ Difficulty losing
Medications adjustments or discontinued
Started on Metformin
Weight loss medication prescribed

100%
98%
10%
6%
94%
100%
100%
80%
100%
4%
8%
100%
98%
98%
96%
88%
86%
84%
80%
46%
6%
0%
62%
12%
6%
2%

96%
100%
96%
86%
94%
92%
25%
20%
48%
76%
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Weight loss medication continued
Weight loss medication change (types or dosing)
Weight loss medication discontinued
Mobil Applications used for weight loss

76%
62%
38%
4%
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APPENDIX B
Template for Assessment and Treatment for Overweight and Obesity
Appointment #1

INITIAL EXAM:
Introduction, what can I do for you? May need to ask for permission to discuss body
weight.
So, I understand you are interested in learning about some ways to obtain your weight
goals?
Complaint:
Past Medical History:
(Positive responses in bold)
Cardiovascular: Afib, CHF, HTN, PE, Stroke, Varicosities, Heart palpitations
Pulmonary: Asthma, Dyspenia, OSA.
Neurologic: Intracranial hypertension, nerve entrapment (carpel tunnel etc.), Seizure
disorders
Musculoskeletal: Altered center of gravity, Impaired balance, Immobility, Lower
back pain, Myalgias, Osteoarthritis, Fibromyalgia, Accidents, Broken bones
Endocrine: Acanthosis Nigricans, DM, Insulin resistance/ Metabolic Syndrome,
Decreased HDL, Hyper lipids, Hyper triglycerides,
Gastrointestinal: Cholelithitis, GERD, Glomerulopathy, Hernias, Nephrolithitis,
urinary incontinence, pelvic prolaspe
Integument: Carbuncles, Cellulitis, Bacterial or fungal skin fold infections, Skin tags,
Stria distensae, Stasis pigmentation, hirsutism
Psycho/ Social: Anxiety, Body image dissatisfaction, Depression, Diminished sex
drive, Eating disorders, Experienced bullying, Feeling unmotivated, Hopelessness,
Impaired intimacy and sexual relationships, PTSD, Work absenteeism or decreased
work production
Any Cancers:
Other:
GYN History: (Positive Responses in Bold)
GYN: PCOS, infertility, Difficulty getting pregnant, HX of reproductive assistance,
heavy, irregular, or painful periods, missed or not having periods, diabetes when
pregnant, Preeclampsia, endometriosis, Adenomyosis
Other:
Past surgical History:
Social History:
Significant others: Tobacco use: yes/ no, ETOH: yes/ no, Illicit drug use: yes/ no
Employment:
Exercise: yes/ no
Feels safe: yes/ no
Support at home: yes/ no
Family History:
Mother:
Father:
Sister:
Sister 2:
Brother:
Brother 2:
Paternal Grandmother:
Paternal Grandfather:
Maternal Grandmother:
Maternal Grandfather:
Allergies: Food:
Medication:
Medications: (Review and bold weight-related medications: Beta-blockers, CCB,
insulins, sulfonylureas, thiazolidinesediones, Meglitinides, glucocorticoids, estrogens,
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Carbamazepine, Gabapentin, Valproate, TCAs, SSRIs, MAOIs, SNRIs, Lithium,
Vigabatrin, Most Antipsychotics, some HAART, some Chemotherapies)
List:
Nutrition History:
Timing:
Frequency:
Who prepares food: Fast-food:
Restaurants:
Meals and Snacks:
24 Hour recall: Breakfast:
Lunch:
Dinner:
Snacks:
Weight History: (when at lowest/ highest)
Behavior History:
Triggers:
Cravings:
or nighttime eating, binge eating, emotional eating,
Cultural/ familial/ community influences:
Support System:
Previous Diets:
Physical Activity History:
Current mobility/ fitness level:
What kind: (frequency, intensity, time)
Success/ failure
Motivation/ Readiness:
Goals: (improve health, quality of life, improve body weight and composition)
Barriers:
Health Maintenance:
PAP:
Mammogram:
Colonoscopy:
Review of Systems: (Positive responses in bold)
Constitutional: Denies significant weight changes, fever, chills, fatigue
Psych: Denies feeling depressed, crying spells, anxiety, sleep disturbances,
hopelessness, feeling guilty, unworthy, dislikes how clothing fits, forgetfulness,
daytime sleepiness, stress, cognitive changes
HEENT: Denies visual changes, headaches, seizures, sinus problems, sore throat,
dental problems, deviated septum,
Respiratory: Denies shortness of breath, cough, hemoptsis, wheezing, snoring,
restless sleep or leg movements
Cardiovascular: Denies chest pain, palpitations, swelling of legs
Gastrointestinal: Denies fecal incontinence, incontinence of flatus, diarrhea,
nausea/vomiting, constipation, bloody stools
Genitourinary: Denies urinary incontinence, urinary urgency, dysuria, dyspareunia,
vaginal dryness
Breast: Denies breast masses, mastalgia, galactorrhea
Endocrine: Denies dry skin, hair loss/growth, abnormal thirst, hot flashes
Integumentary: Denies any rashes lesions, acne
Objective Data:
PHYSICAL EXAM:
VS: BP:
P:
Temp:
R:
WT:
HT:
BMI:
Waist/hip:
Neck circumference: > 16 inches yes/ no ______inches/ cm
General: Well nourished, age-appropriate looking female
Anatomical paradox: apple or pear
Neuro/Psych: Normal mood and affect A&O.
HEENT: Normocephalic, atraumatic,
Neck: supple, no lymphadenopathy, no thyromegaly, no tooth enamel erosion
Tonsils Yes/ No Grade:
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Heart: RRR, no murmurs/rubs/gallops
Lungs: CTA x4
Breast: no lumps or masses
Abdomen: Soft, nontender, nondistended, no masses or hepatospenomegaly, no
hernia noted
Extremities: No clubbing, cyanosis, or edema. No varicosities
Skin: Warm and dry without rash, lesions acne. No acanthosis nigricans, No
intertrigo, venous stasis ulcers, stasis pigmentation, no stria, no Russell sign
Pelvic:
Laboratory Testing:
CBC, CMP, Fasting Lipids, Liver enzymes, HgbA1c, THS/reflex, Insulin, Vitamin D
levels, urine for microalbumin.
Additional Testing:
Hyperinsulinemia: Proinsulin, C-peptide, insulin
Unexplained oligomenorrhea or amenorrhea: Prolactin, estradiol, FSH, LH, HCG
PCOS, hirsutism, acne: testosterone, DHEA
Elevated triglycerides: Apolipoprotein B or particle number
Inflammation, Myalgias: C-reactive protein
Fatigue, Anemia: Fe+ studies: Fe+, total iron building capacity, ferritin
ASSESSMENT:
DX:
Patient Management:
TREATMENT:
POC:
1. Nutrition:
Carbs: (low carb: 50-150 /day, < 30 per 3-hour period, < 20 carbs/day)
Fats:
Increase healthy fats
Protein:
2. Physical activity:
Weight loss: (at least 150 minutes, preferably >300 minutes/ week of moderate or 150
minutes/ week of intense)
Maintenance: (higher levels and intensity >200300 minutes/ week)
3. Behavior therapy:
(Ask, assist, advise, agree, arrange/assist). Motivation/ Goals:
Barriers:
Stress management:
Mobil Apps:
4. Medication:
(FDA approved anti-obesity medications for BMI > 30Kg/m or for overweight BMI >
27 with Type 2 DM, dyslipidemia, or HTN) No improvement after 12 weeks, increase
dosing or consider alternate drug. Please review dosing and side-effects. List initial
dose and titration schedule.
Cravings: Bupropion & Naltrexone/ CONTRAVE
Hunger: (Lorcaserin/ BELVIQ, Phentermine & Topamax/ QSYMIA,
Binge-eating: (VyVanse, Fluoxetine, topiramate, naltrexone)
Night-eating: (behavior therapy)
Diabetic: Liraglutide/ VICTOZA
Combo: Liraglutide/ SAXENDA
5. Referrals:
(Behavioral health, psychiatrist, primary care, cardiologist, endocrinologist, Sleep
medicine)
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FU: 8-12 weeks
Pt Education:
Discussed with patient:
Goals: Discussed most important goals/ motivators and possible barriers. SMART
goals (specific, measurable, assignable, realistic, time-related)
Nutrition: Discussed keeping food diary, reviewed basics of nutrition, reduce
carbohydrates, increase healthy fats (almonds, avocados, cheeses etc.) and protein
(fish, chicken, beef, pork). What is insulin resistance/ metabolic syndrome, PCOS,
DM, menopause and how does it relate to obesity.
Physical activity: Instructed pt to strive for at least 150 minutes, preferably > 300
minutes/ week. Explained to keep moving for NEAT (Non-exercise activity
thermogenesis) Take stairs not elevator etc.
Keep daily activity logs.
Behavior therapy: Discussed triggers and what to do when they occur. Patient has
support system in place. Encouraged mobile app to motivate, track activity and food
intake.
Medication: Discussed how to take medication and potential side/effects
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APPENDIX C
Template for Assessment and Treatment for Overweight and Obesity
Appointment #2
FOLLOW-UP EXAM: (8-12 weeks)
Introduction: How are you doing? What are you enjoying or dislike about the weight
loss program?
Medical changes?
Complaint:
Allergies: Food:
Medication:
(Positives in bold)
Medications: (Review and bold weight-related medications: Beta-blockers, CCB,
insulins, sulfonylureas, thiazolidinesediones, Meglitinides, glucocorticoids, estrogens,
Carbamazepine, Gabapentin, Valproate, TCAs, SSRIs, MAOIs, SNRIs, Lithium,
Vigabatrin, Most Antipsychotics, some HAART, some Chemotherapies)
List:
Nutrition:
Timing:
Frequency:
Fast-food:
Restaurants:
Meals and Snacks:
24 Hour recall: Breakfast:
Lunch:
Dinner:
Snacks:
Behavior Therapy:
Triggers:
Cravings:
or nighttime eating, binge eating, emotional eating,
Cultural/ familial/ community influences:
Behavioral health: Yes/ No Psychiatry: Yes/ No
Stress management, hobbies, self-care
Assess motivation, reinforce/set new goals, review barriers
Support System:
Physical Activity:
Current mobility/ fitness level:
What kind: (frequency, intensity, time)
Success/ failure
Motivation/ Readiness:
Goals: (improve health, quality of life, improve body weight and composition)
Barriers:
Medication: (positive in bold).
Cravings: Bupropion & Naltrexone/ CONTRAVE (dosing)
Hunger: (Lorcaserin/ BELVIQ, Phentermine & Topamax/ QSYMIA, (dosing)
Binge-eating: (VyVanse, Fluoxetine, topiramate, naltrexone) (dosing)
Night-eating: (behavior therapy)
Diabetic: Liraglutide/ VICTOZA (dosing)
Combo: Liraglutide/ SAXENDA (dosing)
Side Effects:
Review of Systems: (Positive responses in bold)
Constitutional: Denies significant weight changes, fever, chills, fatigue
Psych: Denies feeling depressed, crying spells, anxiety, sleep disturbances,
hopelessness, feeling guilty, unworthy, dislikes how clothing fits, forgetfulness,
daytime sleepiness, stress, cognitive changes
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HEENT: Denies visual changes, headaches, seizures, sinus problems, sore throat,
dental problems, deviated septum,
Respiratory: Denies shortness of breath, cough, hemoptsis, wheezing, snoring,
restless sleep or leg movements
Cardiovascular: Denies chest pain, palpitations, swelling of legs
Gastrointestinal: Denies fecal incontinence, incontinence of flatus, diarrhea,
nausea/vomiting, constipation, bloody stools
Genitourinary: Denies urinary incontinence, urinary urgency, dysuria, dyspareunia,
vaginal dryness
Breast: Denies breast masses, mastalgia, galactorrhea
Endocrine: Denies dry skin, hair loss/growth, abnormal thirst, hot flashes
Integumentary: Denies any rashes lesions, acne
Objective Data:
Physical Exam:
VS: BP:
P:
Temp:
R:
WT:
HT:
BMI:
Waist/hip:
Neck circumference: > 16 inches yes/ no ______inches/ cm
General: Well nourished, age-appropriate looking female.
Anatomical paradox: apple or pear
Neuro/Psych: Normal mood and affect A&O.
HEENT: Normocephalic, atraumatic,
Neck: supple, no lymphadenopathy, no thyromegaly, no tooth enamel erosion
Tonsils Yes/ No Grade:
Heart: RRR, no murmurs/rubs/gallops
Lungs: CTA x4
Breast: no lumps or masses
Abdomen: Soft, nontender, nondistended, no masses or hepatospenomegaly, no
hernia noted
Extremities: No clubbing, cyanosis, or edema. No varicosities
Skin: Warm and dry without rash, lesions acne. No acanthosis nigricans, No
intertrigo, venous stasis ulcers, stasis pigmentation, no stria, no Russell sign
Pelvic:
Laboratory Testing:
Assessment:
DX:
Patient Management:
TREATMENT:
POC:
1. Nutrition:
Carbs: (low carb: 50-150 /day, < 30 per 3-hour period, < 20 carbs/day) Fats:
Increase healthy fats
Protein:
2. Physical activity:
Weight loss: (at least 150 minutes, preferably >300 minutes/ week of moderate or 150
minutes/ week of intense)
Maintenance: (higher levels of activity and intensity >200-300 minutes/ week)
3. Behavior therapy:
(Ask, assist, advise, agree, arrange/assist). Motivation/ Goals:
Barriers:
Stress management:
Mobile Apps: Yes/ No
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4. Medication/Dosing changes:
5. Referrals:
(Behavioral health, psychiatrist, primary care, cardiologist, endocrinologist, Sleep
medicine)
FU: 12 weeks
Pt Education:
Discussed with patient:
Goals: Discussed most important goals/ motivators and possible barriers. SMART
goals (specific, measurable, assignable, realistic, time-related)
Nutrition: Discussed keeping food diary, reviewed basics of nutrition, reduce
carbohydrates, increase healthy fats (almonds, avocados, cheeses etc.) and protein
(fish, chicken, beef, pork). What is insulin resistance/ metabolic syndrome, PCOS,
DM, menopause and how does it relate to obesity.
Physical activity: Instructed pt to strive for at least 150 minutes, preferably > 300
minutes/ week. Explained to keep moving for NEAT (Non-exercise activity
thermogenesis) Take stairs not elevator etc.
Keep daily activity logs.
Behavior therapy: Discussed triggers and what to do when they occur. Patient has
support system in place. Encouraged mobile app to motivate, track activity and food
intake.
Medication: Discussed how to take medication and potential side/effects
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APPENDIX D
Template for Assessment and Treatment for Overweight and Obesity
Appointment #3
FOLLOW-UP EXAM: (6 months)
Introduction: How are you doing? What are you enjoying or dislike about the weight
loss program?
Medical changes?
Complaint:
Allergies: Food:
Medication:
(Positive in bold)
Medications: (Review and bold weight-related medications: Beta-blockers, CCB,
insulins, sulfonylureas, thiazolidinesediones, Meglitinides, glucocorticoids, estrogens,
Carbamazepine, Gabapentin, Valproate, TCAs, SSRIs, MAOIs, SNRIs, Lithium,
Vigabatrin, Most Antipsychotics, some HAART, some Chemotherapies)
List:
Nutrition:
Timing:
Frequency:
Fast-food:
Restaurants:
Meals and Snacks:
24 Hour recall: Breakfast:
Lunch:
Dinner:
Snacks:
Behavior Therapy:
Triggers:
Cravings:
or nighttime eating, binge eating, emotional eating,
Cultural/ familial/ community influences:
Behavioral health: Yes/ No Psychiatry: Yes/ No
Stress management, hobbies, self-care
Motivation, reinforce/set new goals, review barriers
Support system:
Physical Activity:
Current mobility/ fitness level:
What kind: (frequency, intensity, time)
Success/ failure
Motivation/ Readiness:
Goals: (improve health, quality of life, improve body weight and composition)
Barriers:
Medication: (Positive in Bold)
Cravings: Bupropion & Naltrexone/ CONTRAVE (dosing)
Hunger: (Lorcaserin/ BELVIQ, Phentermine & Topamax/ QSYMIA, (dosing)
Binge-eating: (VyVanse, Fluoxetine, topiramate, naltrexone) (dosing)
Night-eating: (behavior therapy)
Diabetic: Liraglutide/ VICTOZA (dosing)
Combo: Liraglutide/ SAXENDA (dosing)
Side Effects:
Review of Systems: (Positive responses in bold)
Constitutional: Denies significant weight changes, fever, chills, fatigue
Psych: Denies feeling depressed, crying spells, anxiety, sleep disturbances,
hopelessness, feeling guilty, unworthy, dislikes how clothing fits, forgetfulness,
daytime sleepiness, stress, cognitive changes
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HEENT: Denies visual changes, headaches, seizures, sinus problems, sore throat,
dental problems, deviated septum,
Respiratory: Denies shortness of breath, cough, hemoptsis, wheezing, snoring,
restless sleep or leg movements
Cardiovascular: Denies chest pain, palpitations, swelling of legs
Gastrointestinal: Denies fecal incontinence, incontinence of flatus, diarrhea,
nausea/vomiting, constipation, bloody stools
Genitourinary: Denies urinary incontinence, urinary urgency, dysuria, dyspareunia,
vaginal dryness
Breast: Denies breast masses, mastalgia, galactorrhea
Endocrine: Denies dry skin, hair loss/growth, abnormal thirst, hot flashes
Integumentary: Denies any rashes lesions, acne
Objective Data:
Physical Exam:
VS: BP:
P:
Temp:
R:
WT:
HT:
BMI:
Waist/hip:
Neck circumference: > 16 inches yes/ no ______inches/ cm
General: Well nourished, age-appropriate looking female.
Anatomical paradox: apple or pear
Neuro/Psych: Normal mood and affect A&O.
HEENT: Normocephalic, atraumatic,
Neck: supple, no lymphadenopathy, no thyromegaly, no tooth enamel erosion
Tonsils Yes/ No Grade:
Heart: RRR, no murmurs/rubs/gallops
Lungs: CTA x4
Breast: no lumps or masses
Abdomen: Soft, nontender, nondistended, no masses or hepatospenomegaly, no
hernia noted
Extremities: No clubbing, cyanosis, or edema. No varicosities
Skin: Warm and dry without rash, lesions acne. No acanthosis nigricans, No
intertrigo, venous stasis ulcers, stasis pigmentation, no stria, no Russell sign
Pelvic:
Laboratory Testing: (Optional) Lipids, HgA1c, Insulin, Vitamin D
Assessment:
DX:
Patient Management:
TREATMENT:
POC:
1. Nutrition:
Carbs: (low carb: 50-150 /day, < 30 per 3-hour period, < 20 carbs/day)
Fats:
Increase healthy fats
Protein:
2. Physical activity:
Weight loss: (at least 150 minutes preferably >300 minutes/ week of moderate or 150
minutes/ week of intense)
Maintenance: (higher levels and intensity >
200-300 minutes/ week)
3. Behavior therapy:
Motivation/ Goals:
Barriers:
Stress management:
Mobile Apps: Yes/ No
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4. Medication/Dosing changes:
5. Referrals:
(Behavioral health, psychiatrist, primary care, cardiologist, endocrinologist, Sleep
medicine)
FU: 12 weeks
Pt Education:
Discussed with patient:
Goals: Discussed most important goals/ motivators and possible barriers. SMART
goals (specific, measurable, assignable, realistic, time-related)
Nutrition: Discussed keeping food diary, reviewed basics of nutrition, reduce
carbohydrates, increase healthy fats (almonds, avocados, cheeses etc.) and protein
(fish, chicken, beef, pork). What is insulin resistance/ metabolic syndrome, PCOS,
DM, menopause and how does it relate to obesity.
Physical activity: Instructed pt to strive for at least150 minutes preferably >300
minutes/ week. Explained to keep moving for NEAT (Non-exercise activity
thermogenesis) Take stairs not elevator etc.
Keep daily activity logs.
Behavior therapy: Discussed triggers and what to do when they occur. Patient has
support system in place. Encouraged mobile app to motivate, track activity and food
intake.
Medication: Discussed how to take medication and potential side/effects
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APPENDIX E
Health History
(To be Used with Current Facility Patient Health History Form)
Name:
Date of Birth:

Date:
Race/Ethnicity:

_________
___

What are your expectations from treatment? Please be specific.
___
_____________________________________________________________________
_____________________________________________________________________
Do you have any allergies? (Please list) ____________________________________
_____________________________________________________________________
Medical History: (Please Circle)
Cardiovascular: AFib, Congestive heart failure, High Blood Pressure, Pulmonary
Embolism, Stroke, Varicose veins, Heart palpitations
Pulmonary: Asthma, Difficulty breathing, Sleep Apnea, Ever been told you snore
*Please fill out Epworth Sleepiness Scale Form
Neurologic: High blood Pressure in the Brain, Nerve entrapment (carpel tunnel etc.),
Seizure disorders
Musculoskeletal: Altered center of gravity, Impaired balance, Immobility, Lower
back pain, Myalgias, Osteoarthritis, Fibromyalgia, Accidents, Broken bones
Endocrine: Acanthosis Nigricans, Diabetes, Insulin resistance/ Metabolic Syndrome,
Decreased HDL (good cholesterol), High cholesterol, High triglycerides, Thyroid
Disorders, Hashimotos Disease, Inflammation, Rheumatoid Disorders
Gastrointestinal: Cholelithitis, GERD, Glomerulopathy, Hernias, Nephrolithitis,
urinary incontinence, pelvic prolaspe
Integument: Carbuncles, Cellulitis, Bacterial or fungal skin fold infections, Skin
tags, Stretch marks, Discolored skin from poor circulation, Unwanted or excessive
hair growth (facial etc.)
Psycho/ Social: Tiredness, Anxiety, Body image dissatisfaction, Depression,
Diminished sex drive, Eating disorders, Experienced bullying, Feeling unmotivated,
Hopelessness, Impaired intimacy and sexual relationships, PTSD, Work absenteeism
or decreased work production
*Please fill out Patient Health Questionnaire (PHQ-9)
Any Cancers:
_________________________________________________________________
Anything else?
_________________________________________________________________
GYN History:
Number of pregnancies: ______
Birth Control: ______________
GYN: Any history of: PCOS, infertility, Difficulty getting pregnant, history of
reproductive assistance, heavy, irregular, or painful periods, missed or not having
periods, diabetes when pregnant, preeclampsia, endometriosis, adenomyosis
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Other:
_____________________________________________________________________
Past surgical History:
_____________________________________________________________________
Serious Accident/ Injuries?
_____________________________________________________________________
Social History: (Please Circle)
Significant others (who):
Tobacco use: yes/ no, ETOH: yes/ no, Illicit drug use: yes/ no
Employment (where):
Exercise: yes/ no
Feels safe: yes/ no
Support at home: yes/ no
Family History: (Please Circle)
Any serious or weight-related diseases?
Mother:
Father:
Sister:
Sister 2:
Brother:
Brother 2:
Paternal Grandmother:
Paternal Grandfather:
Maternal Grandmother:
Maternal Grandfather:
Nutritional History: (Please Circle)
*Please fill out 24 -Hour Diet Recall Form
Eat: Breakfast
Lunch
Dinner
Behavior History: (Please Circle)
Cravings
Hunger
Triggers
Binge Eat
Night Eating
Emotional Eating
Cook at Home
Eat Fast-Food
Eat at Restaurants
Support System
History of Abuse
Ever tried to hurt yourself

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

Physical Activity History: (Please Circle)
Exercise
Yes
Work
Yes
Goals
Yes
Barriers
Yes

No
No
No
No
No
No
No
No
No
No
No
No

No
No
No
No

Health Maintenance: (Please Circle and Write in Date)
PAP
Mammogram
Colonoscopy

Snacks

